BCAB
Price
$3.17
Change
-$0.08 (-2.46%)
Updated
May 6, 6:59 PM EST
3 days until earnings call
DNLI
Price
$17.14
Change
+$0.01 (+0.06%)
Updated
May 6, 6:59 PM EST
92 days until earnings call
Ad is loading...

BCAB vs DNLI ᐉ Comparison: Which is Better to Invest?

Header iconBCAB vs DNLI Comparison
Open Charts BCAB vs DNLIBanner chart's image
BioAtla
Price$3.17
Change-$0.08 (-2.46%)
Volume$338.99K
CapitalizationN/A
Denali Therapeutics
Price$17.14
Change+$0.01 (+0.06%)
Volume$411.85K
CapitalizationN/A
View a ticker or compare two or three
BCAB vs DNLI Comparison Chart

Loading...

BCABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCAB vs. DNLI commentary
May 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Hold and DNLI is a Hold.

COMPARISON
Comparison
May 07, 2024
Stock price -- (BCAB: $3.25 vs. DNLI: $17.14)
Brand notoriety: BCAB and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 68% vs. DNLI: 76%
Market capitalization -- BCAB: $156.35M vs. DNLI: $2.44B
BCAB [@Biotechnology] is valued at $156.35M. DNLI’s [@Biotechnology] market capitalization is $2.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $545.88B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BCAB is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 5 TA indicator(s) are bullish while DNLI’s TA Score has 5 bullish TA indicator(s).

  • BCAB’s TA Score: 5 bullish, 4 bearish.
  • DNLI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than DNLI.

Price Growth

BCAB (@Biotechnology) experienced а +27.95% price change this week, while DNLI (@Biotechnology) price change was +11.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.75%. For the same industry, the average monthly price growth was -3.30%, and the average quarterly price growth was +64.67%.

Reported Earning Dates

BCAB is expected to report earnings on Aug 08, 2024.

DNLI is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+3.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCAB with price predictions.
OPEN
A.I.dvisor published
a Summary for DNLI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DNLI($2.44B) has a higher market cap than BCAB($156M). BCAB YTD gains are higher at: 32.114 vs. DNLI (-20.130).
BCABDNLIBCAB / DNLI
Capitalization156M2.44B6%
EBITDAN/AN/A-
Gain YTD32.114-20.130-160%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABDNLI
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
BCABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIVYX40.500.59
+1.48%
Putnam International Capital Opp Y
FCFMX16.790.20
+1.21%
Fidelity Series Total Market Index
MICHX9.350.06
+0.65%
Matthews China Small Companies Instl
CCCNX5.530.03
+0.55%
Center Coast Brookfield Midstream Foc I
PSGCX24.15-0.15
-0.62%
Virtus KAR Small-Cap Growth C

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with CTMX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then CTMX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+2.85%
CTMX - BCAB
47%
Loosely correlated
-1.56%
STRO - BCAB
47%
Loosely correlated
-2.79%
CYTK - BCAB
43%
Loosely correlated
+1.45%
DNLI - BCAB
41%
Loosely correlated
+1.96%
AXON - BCAB
41%
Loosely correlated
+0.57%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been closely correlated with BEAM. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+1.96%
BEAM - DNLI
69%
Closely correlated
+1.80%
NTLA - DNLI
66%
Loosely correlated
+1.42%
JANX - DNLI
59%
Loosely correlated
+3.76%
ALLO - DNLI
51%
Loosely correlated
+3.37%
XNCR - DNLI
51%
Loosely correlated
+2.03%
More